Follow the people · Insider
David L. Mahoney
David L. Mahoney files insider transactions with the SEC as a director of Corcept Therapeutics (CORT). We hold 2 disclosed purchases and sales filed since 22 February 2006, 2 of them in the last 90 days.
- Files forCORT
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure20 August 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 February 2006 — 18 August 2026Director · Corcept Therapeutics (CORT)120 Form 4 lines · source: SEC Form 4
- Filed 15 April 2014 — 24 November 2021Director · Adamas Pharmaceuticals (ADMS)26 Form 4 lines · source: SEC Form 4
- Filed 25 April 2006 — 14 May 2019Director · Symantec (SYMC)47 Form 4 lines · source: SEC Form 4
- Filed 6 June 2006 — 16 October 2008Director · Tercica (TRCA)10 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 4,984 shares of Corcept TherapeuticsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 91,167 shares of Corcept TherapeuticsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 7,055 shares of Corcept TherapeuticsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 400 shares of Corcept TherapeuticsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
- ▼ sold on the open market 20,000 shares of Corcept TherapeuticsSEC Form 418 June 2026Common Stock · traded 17 June 2026 · filed 18 June 2026
- was granted 12,500 shares of Corcept Therapeutics (a derivative holding)SEC Form 426 May 2026Stock Option (right to buy) · traded 21 May 2026 · filed 26 May 2026
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- had shares withheld for tax on 5,469 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- gave away 24,531 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option (right to buy) · traded 13 March 2026 · filed 17 March 2026
- acquired or disposed of, other 24,531 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option (right to buy) · traded 13 March 2026 · filed 17 March 2026
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- had shares withheld for tax on 5,469 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- gave away 24,531 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- acquired or disposed of, other 24,531 shares of Corcept TherapeuticsSEC Form 417 March 2026Common Stock · traded 13 March 2026 · filed 17 March 2026
- was granted 15,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 June 2025Stock option (right to buy) · traded 10 June 2025 · filed 12 June 2025
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 May 2025Stock option (right to buy) · traded 16 May 2025 · filed 20 May 2025
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- had shares withheld for tax on 2,648 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▼ sold on the open market 23,829 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▼ sold on the open market 3,523 shares of Corcept TherapeuticsSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 421 May 2024Stock option (right to buy) · traded 17 May 2024 · filed 21 May 2024
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 412 April 2024Stock option (right to buy) · traded 10 April 2024 · filed 12 April 2024
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- had shares withheld for tax on 2,194 shares of Corcept TherapeuticsSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- acquired or disposed of, other 27,806 shares of Corcept TherapeuticsSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- acquired or disposed of, other 27,806 shares of Corcept TherapeuticsSEC Form 412 April 2024Common Stock · traded 10 April 2024 · filed 12 April 2024
- gave away 17,420 shares of Corcept TherapeuticsSEC Form 431 August 2023Common Stock · traded 29 August 2023 · filed 31 August 2023
- gave away 34,850 shares of Corcept TherapeuticsSEC Form 431 August 2023Common Stock · traded 29 August 2023 · filed 31 August 2023
- gave away 34,850 shares of Corcept TherapeuticsSEC Form 431 August 2023Common Stock · traded 29 August 2023 · filed 31 August 2023
- ▼ sold on the open market 10,000 shares of Corcept TherapeuticsSEC Form 416 August 2023Common Stock · traded 14 August 2023 · filed 16 August 2023
- ▼ sold on the open market 15,000 shares of Corcept TherapeuticsSEC Form 416 August 2023Common Stock · traded 14 August 2023 · filed 16 August 2023
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 423 May 2023Stock option (right to buy) · traded 19 May 2023 · filed 23 May 2023
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 49 May 2023Stock option (right to buy) · traded 8 May 2023 · filed 9 May 2023
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 49 May 2023Common Stock · traded 8 May 2023 · filed 9 May 2023
- had shares withheld for tax on 2,197 shares of Corcept TherapeuticsSEC Form 49 May 2023Common Stock · traded 8 May 2023 · filed 9 May 2023
- gave away 26,030 shares of Corcept TherapeuticsSEC Form 414 February 2023Common Stock · traded 13 December 2022 · filed 14 February 2023
- gave away 21,297 shares of Corcept TherapeuticsSEC Form 414 February 2023Common Stock · traded 16 December 2022 · filed 14 February 2023
- was granted 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 42 June 2022Stock option (right to buy) · traded 31 May 2022 · filed 2 June 2022
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 431 May 2022Stock Option (Right to Buy) · traded 27 May 2022 · filed 31 May 2022
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 431 May 2022Common Stock · traded 27 May 2022 · filed 31 May 2022
- had shares withheld for tax on 5,786 shares of Corcept TherapeuticsSEC Form 431 May 2022Common Stock · traded 27 May 2022 · filed 31 May 2022
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 418 March 2022Stock Option (Right to Buy) · traded 11 May 2021 · filed 18 March 2022
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 418 March 2022Common Stock · traded 11 May 2021 · filed 18 March 2022
- had shares withheld for tax on 6,484 shares of Corcept TherapeuticsSEC Form 418 March 2022Common Stock · traded 11 May 2021 · filed 18 March 2022
- gave away 112,500 shares of Corcept TherapeuticsSEC Form 418 March 2022Common Stock · traded 11 May 2021 · filed 18 March 2022
- gave away 112,500 shares of Corcept TherapeuticsSEC Form 418 March 2022Common Stock · traded 11 May 2021 · filed 18 March 2022
- returned to the issuer 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 424 November 2021Stock Option (Right to Buy) · traded 24 November 2021 · filed 24 November 2021
- returned to the issuer 40,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 424 November 2021Stock Option (Right to Buy) · traded 24 November 2021 · filed 24 November 2021
- returned to the issuer 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 424 November 2021Stock Option (Right to Buy) · traded 24 November 2021 · filed 24 November 2021
- returned to the issuer 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 424 November 2021Stock Option (Right to Buy) · traded 24 November 2021 · filed 24 November 2021
- disposed of in a tender offer 5,000 shares of Adamas PharmaceuticalsSEC Form 424 November 2021Common Stock · traded 24 November 2021 · filed 24 November 2021
- disposed of in a tender offer 112,781 shares of Adamas PharmaceuticalsSEC Form 424 November 2021Common Stock · traded 24 November 2021 · filed 24 November 2021
- was granted 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 44 June 2021Stock Option (Right to Buy) · traded 2 June 2021 · filed 4 June 2021
- was granted 5,000 shares of Adamas PharmaceuticalsSEC Form 44 June 2021Common Stock · traded 2 June 2021 · filed 4 June 2021
- was granted 20,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 428 May 2021Stock Option (Right to Buy) · traded 26 May 2021 · filed 28 May 2021
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 413 May 2021Common Stock · traded 11 May 2021 · filed 13 May 2021
- had shares withheld for tax on 6,484 shares of Corcept TherapeuticsSEC Form 413 May 2021Common Stock · traded 11 May 2021 · filed 13 May 2021
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 413 May 2021Stock Option (Right to Buy) · traded 11 May 2021 · filed 13 May 2021
- exercised options over 48,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 416 March 2021Stock Option (Right to Buy) · traded 12 March 2021 · filed 16 March 2021
- exercised options over 48,000 shares of Adamas PharmaceuticalsSEC Form 416 March 2021Common Stock · traded 12 March 2021 · filed 16 March 2021
- was granted 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 45 June 2020Stock Option (Right to Buy) · traded 3 June 2020 · filed 5 June 2020
- was granted 5,000 shares of Adamas PharmaceuticalsSEC Form 45 June 2020Common Stock · traded 3 June 2020 · filed 5 June 2020
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 429 May 2020Stock Option (Right to Buy) · traded 27 May 2020 · filed 29 May 2020
- exercised options over 38,984 shares of Corcept Therapeutics (a derivative holding)SEC Form 427 May 2020Stock Option (Right to Buy) · traded 22 May 2020 · filed 27 May 2020
- exercised options over 38,984 shares of Corcept TherapeuticsSEC Form 427 May 2020Common Stock · traded 22 May 2020 · filed 27 May 2020
- exercised options over 33,332 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 418 September 2019Stock Option (Right to Buy) · traded 17 September 2019 · filed 18 September 2019
- exercised options over 33,332 shares of Adamas PharmaceuticalsSEC Form 418 September 2019Common Stock · traded 17 September 2019 · filed 18 September 2019
- was granted 40,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 413 September 2019Stock Option (Right to Buy) · traded 11 September 2019 · filed 13 September 2019
- was granted 25,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 June 2019Stock Option (Right to Buy) · traded 18 June 2019 · filed 20 June 2019
- was granted 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 46 June 2019Stock Option (Right to Buy) · traded 5 June 2019 · filed 6 June 2019
- exercised options over 50,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 44 June 2019Stock Option (Right to Buy) · traded 3 June 2019 · filed 4 June 2019
- exercised options over 50,000 shares of Corcept TherapeuticsSEC Form 44 June 2019Common Stock · traded 3 June 2019 · filed 4 June 2019
- was granted 14,124 shares of SymantecSEC Form 415 May 2019Common Stock · traded 14 May 2019 · filed 15 May 2019
- was granted 2,568 shares of SymantecSEC Form 415 May 2019Common Stock · traded 14 May 2019 · filed 15 May 2019
- was granted 25,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 422 August 2018Stock Option (Right to Buy) · traded 20 August 2018 · filed 22 August 2018
- was granted 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 47 June 2018Stock Option (Right to Buy) · traded 6 June 2018 · filed 7 June 2018
- was granted 12,320 shares of SymantecSEC Form 421 May 2018Common Stock · traded 17 May 2018 · filed 21 May 2018
- was granted 10,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 430 November 2017Stock Option (Right to Buy) · traded 29 November 2017 · filed 30 November 2017
- gave away 15,785 shares of Corcept TherapeuticsSEC Form 417 November 2017Common Stock · traded 16 November 2017 · filed 17 November 2017
- exercised options over 6,510 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 12 July 2017 · filed 20 July 2017
- ▼ sold on the open market 6,510 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 12 July 2017 · filed 20 July 2017
- exercised options over 484 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 13 July 2017 · filed 20 July 2017
- ▼ sold on the open market 484 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 13 July 2017 · filed 20 July 2017
- exercised options over 6,510 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 July 2017Stock Option (Right to Buy) · traded 12 July 2017 · filed 20 July 2017
- exercised options over 484 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 July 2017Stock Option (Right to Buy) · traded 13 July 2017 · filed 20 July 2017
- exercised options over 6,091 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 18 July 2017 · filed 20 July 2017
- ▼ sold on the open market 6,091 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 18 July 2017 · filed 20 July 2017
- exercised options over 16,915 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 19 July 2017 · filed 20 July 2017
- ▼ sold on the open market 16,915 shares of Corcept TherapeuticsSEC Form 420 July 2017Common Stock · traded 19 July 2017 · filed 20 July 2017
- exercised options over 6,091 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 July 2017Stock Option (Right to Buy) · traded 18 July 2017 · filed 20 July 2017
- exercised options over 16,915 shares of Corcept Therapeutics (a derivative holding)SEC Form 420 July 2017Stock Option (Right to Buy) · traded 19 July 2017 · filed 20 July 2017
- ▼ sold on the open market 6,510 shares of Corcept TherapeuticsSEC Form 414 July 2017Common Stock · traded 12 July 2017 · filed 14 July 2017
- ▼ sold on the open market 484 shares of Corcept TherapeuticsSEC Form 414 July 2017Common Stock · traded 13 July 2017 · filed 14 July 2017
- was granted 15,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 42 June 2017Stock Option (Right to Buy) · traded 1 June 2017 · filed 2 June 2017
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 426 May 2017Stock Option (Right to Buy) · traded 24 May 2017 · filed 26 May 2017
- was granted 8,593 shares of SymantecSEC Form 416 May 2017Common Stock · traded 15 May 2017 · filed 16 May 2017
- gave away 33,647 shares of Corcept TherapeuticsSEC Form 414 February 2017Common Stock · traded 29 December 2016 · filed 14 February 2017
- exercised options over 30,000 shares of Corcept TherapeuticsSEC Form 414 November 2016Common Stock · traded 11 November 2016 · filed 14 November 2016
- ▼ sold on the open market 30,000 shares of Corcept TherapeuticsSEC Form 414 November 2016Common Stock · traded 11 November 2016 · filed 14 November 2016
- exercised options over 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 414 November 2016Stock Option (Right to Buy) · traded 11 November 2016 · filed 14 November 2016
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 422 July 2016Stock Option (Right to Buy) · traded 21 July 2016 · filed 22 July 2016
- was granted 15,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 47 June 2016Stock Option (Right to Buy) · traded 3 June 2016 · filed 7 June 2016
- was granted 16,233 shares of SymantecSEC Form 419 May 2016Common Stock · traded 17 May 2016 · filed 19 May 2016
- was granted 2,951 shares of SymantecSEC Form 419 May 2016Common Stock · traded 17 May 2016 · filed 19 May 2016
- ▼ sold on the open market 33,828 shares of Corcept TherapeuticsSEC Form 49 July 2015Common stock · traded 8 July 2015 · filed 9 July 2015
- was granted 30,000 shares of Corcept Therapeutics (a derivative holding)SEC Form 422 June 2015Common stock (Right to buy) · traded 18 June 2015 · filed 22 June 2015
- was granted 9,362 shares of SymantecSEC Form 420 May 2015Common Stock · traded 19 May 2015 · filed 20 May 2015
- was granted 19,000 shares of Adamas Pharmaceuticals (a derivative holding)SEC Form 418 May 2015Stock Option (Right to Buy) · traded 14 May 2015 · filed 18 May 2015
- exercised in-the-money options over 48,952 shares of Corcept TherapeuticsSEC Form 430 March 2015Common Stock · traded 27 March 2015 · filed 30 March 2015
- exercised in-the-money options over 48,952 shares of Corcept Therapeutics (a derivative holding)SEC Form 430 March 2015Warrant (Right to Buy) · traded 27 March 2015 · filed 30 March 2015
- exercised in-the-money options over 35,304 shares of Corcept TherapeuticsSEC Form 424 March 2015Common Stock · traded 20 March 2015 · filed 24 March 2015
- ▼ sold on the open market 16,717 shares of Corcept TherapeuticsSEC Form 424 March 2015Common Stock · traded 20 March 2015 · filed 24 March 2015
- exercised in-the-money options over 30,534 shares of Corcept TherapeuticsSEC Form 424 March 2015Common Stock · traded 20 March 2015 · filed 24 March 2015
- ▼ sold on the open market 14,458 shares of Corcept TherapeuticsSEC Form 424 March 2015Common Stock · traded 20 March 2015 · filed 24 March 2015
- exercised in-the-money options over 35,304 shares of Corcept Therapeutics (a derivative holding)SEC Form 424 March 2015Warrant (Right to Buy) · traded 20 March 2015 · filed 24 March 2015
- exercised in-the-money options over 30,534 shares of Corcept Therapeutics (a derivative holding)SEC Form 424 March 2015Warrant (Right to Buy) · traded 20 March 2015 · filed 24 March 2015
- exercised options over 12,000 shares of SymantecSEC Form 417 December 2014Common Stock · traded 15 December 2014 · filed 17 December 2014
- ▼ sold on the open market 12,000 shares of SymantecSEC Form 417 December 2014Common Stock · traded 15 December 2014 · filed 17 December 2014
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.